Relative reinforcing effects of cocaine, remifentanil, and their combination in rhesus monkeys

被引:36
|
作者
Winger, G
Galuska, CM
Hursh, SR
Woods, JH
机构
[1] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA
[3] Johns Hopkins Univ, Behav Biol Res Ctr, Baltimore, MD USA
关键词
D O I
10.1124/jpet.105.100461
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Human polydrug abusers often take combinations of opioids and stimulants, but it is not clear why. Behavioral economics with demand curve analysis is uniquely able to separate two of the possibilities: that the drug combination increases the reinforcing potency of the component drugs or that the drug combination is a more effective reinforcer than either drug alone. Rhesus monkeys self-administered a range of doses of cocaine, remifentanil, and combinations of the drugs through indwelling intravenous catheters; the number of responses required for each drug infusion increased across drug-availability sessions. Combining small doses of cocaine and remifentanil that by themselves resulted in very low rates of responding yielded rates of responding that were higher than the maximum maintained by any dose of the constituent drugs. Nevertheless, demand curve analysis demonstrated that the drug combination was equally elastic as the component drugs, indicating that it was not more effective as a reinforcer than either cocaine or remifentanil alone. This suggests that enhanced self-administration of this particular drug combination is due primarily to the drug enhancement of the potency of the other drug.
引用
收藏
页码:223 / 229
页数:7
相关论文
共 50 条
  • [1] Evaluation of the Reinforcing Effect of Quetiapine, Alone and in Combination with Cocaine, in Rhesus Monkeys
    Brutcher, Robert E.
    Nader, Susan H.
    Nader, Michael A.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 356 (02): : 244 - 250
  • [2] Effects of Varenicline on the Reinforcing and Discriminative Stimulus Effects of Cocaine in Rhesus Monkeys
    Gould, Robert W.
    Czoty, Paul W.
    Nader, Susan H.
    Nader, Michael A.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 339 (02): : 678 - 686
  • [3] Effects of varenicline on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys
    Gould, Robert Warren
    Czoty, Paul W.
    Nader, Susan H.
    Nader, Michael A.
    [J]. FASEB JOURNAL, 2009, 23
  • [4] Relative reinforcing effects of different benzodiazepine doses for rhesus monkeys
    Gomez, TH
    Roache, JD
    Meisch, RA
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2002, 68 (03) : 275 - 283
  • [5] Lorcaserin Reduces the Discriminative Stimulus and Reinforcing Effects of Cocaine in Rhesus Monkeys
    Collins, Gregory T.
    Gerak, Lisa R.
    Javors, Martin A.
    France, Charles P.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 356 (01): : 85 - 95
  • [6] Effects of chronic methylphenidate treatment on the reinforcing strength of cocaine in rhesus monkeys
    Czoty, Paul W.
    Martelle, Susan E.
    Gould, Robert W.
    Nader, Michael A.
    [J]. FASEB JOURNAL, 2012, 26
  • [7] Effects of in utero cocaine exposure on the relative reinforcing strength of cocaine in adult rhesus monkeys using a delay discounting procedure.
    Brutcher, Robert E.
    Nader, Michael A.
    [J]. FASEB JOURNAL, 2011, 25
  • [8] Effects of Lorcaserin on Reinstatement of Responding Previously Maintained by Cocaine or Remifentanil in Rhesus Monkeys
    Gerak, Lisa R.
    Collins, Gregory T.
    Maguire, David R.
    France, Charles P.
    [J]. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2019, 27 (01) : 78 - 86
  • [9] GABAA Receptor Subtypes and the Reinforcing Effects of Benzodiazepines in Remifentanil-Experienced Rhesus Monkeys
    Berro, Lais F.
    Rowlett, James K.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2020, 213
  • [10] Discriminative and Reinforcing Stimulus Effects of Nicotine, Cocaine, and Cocaine plus Nicotine Combinations in Rhesus Monkeys
    Mello, Nancy K.
    Newman, Jennifer L.
    [J]. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2011, 19 (03) : 203 - 214